SummarY: This article describes the localization of intact Insulin-containing intrahepilllc islets after combined liver-islet allotransplantation. The patient was a 36-year-old woman who underwent upper abdominal exenteration for neuroendocrine carcinoma: 289.000 islets were transplanted via portal vein infusion Immediately after complete revascularization of the liver. ImmunosuppressIOn was wnh low-dose FK-506. OKT3 and steroids were used to treat one rejection episode 2 weeks after transplantation. but the patient subsequently developed multiple infections and died 109 days after transplantation. At autopsy. the transplanted liver did not show any sign of rejection and well-pt!t!served islets were present in portal triads sampled from the anterior inferior edge of the right lobe. Immunohistochemical labeling confirmed the presence of insulin-containing cells. This finding indicated that human islets can survive after intrahepatic allotransplantation. despite positive cross-match with no HLA antigen match. suggesting that upper abdominal exenteration and liver transplantation may constitute a protective factor for the surVIval of allogeneIc human islets.
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Recent improvements in islet separation and purification procedures (1-6) have resulted in prolonged insulin independence after human islet allotransplantation (7) (8) (9) (10) . demoRstrnnng that it is pos\Ible to reverse diabetes with islets obtained from ~me (7) or multiple (X.9) pancreas donors. The ma,jor obstacle to wider clinical application of islet transplantation is the vulnerability of the human islets to immune rejection.
I t has been shown In both animals and humans t hat liver allografts can induce a ~tate of donorpecilic unresponsiveness to vascularized organ al- lografts such as the heart or kidney (10) . Similar results can be achieved with infusion of allogeneic intrahepatic islets when islets are infused 24 h after a liver transplant ( ((l) . This article Jescribes localization of insulincontaining intrahepatic islets at autopsy in a 36-year-old woman who underwent upper abdominal exenteration and combined liver-Islct allotransplantation (7l.
CASE REPORT
The patient was a 3h-vear-oIJ woman with a history of neurofibromatOSIs since chilJhood. In 1980. she developed hiliary ohstruction and secondarv biliary cirrhosis with portal hypertcnsion and esophageal varices (treated with endoscopic sclero-therapy). In 1989. she was found to have a periampullary pancreatic mass diagnosed by biopsy to be a neuroendocrine carcinoma. After exploratory laparotomy, a portal angiogram was done. demonstrating splenic vein invasion by the tumor. which excluded a splenorenal shunt as a therapeutic option. A decision was made to perform a liver transplant and not to decompress the portal system with an alternative procedure. to avoid subsequent hepatic encephalopathy.
On February 10. 1990 . the patient underwent combined liver and islet allotransplantation following resection of a cluster of abdominal organs including the liver. stomach. duodenum. proximal jejunum. transverse colon. spleen. and the entire pancreas. The patient was not diabetic before surgery
• e' .
•• and thus had not been on insulin. There was no C-peptide response to glucagon in the interval between native organ removal and islet infusion, indicating that all native insulin-producing cells were removed. Pancreas and liver were obtained from a multiorgan. 19-year-old. female. cytomegalovirus (CMV)-seropositive donor. The recipient was CMV -seronegative, The islets were separated by a modification (2) of the automated method for human islet isolation ( I). Purification of the endocrine component was by Eurocollins-Ficoll discontinuous gradients (II). using a cell separator (3.4) (COBE 2991. Lakewood. CO. U.S.A.). Immediately following complete liver allograft revascularization (7), 289.000 islets. average diameter of 150 fJ. On May 16. 1990 . the patient developed gramnegative sepsis (Aeromolllls hvJropizililil. and all immunosuppressive therapy was discontinued on May It). Despite aggressive antibiotic and supportive medical therapy. the patient became progres-"ively obtunded and died lOt) days after transplantation. Postmortem examination revealed enteritis ;tnd hronchopneumonia. with subsequent sepsis as the cause of death. The liver allograft showed steatosis and cholestasis. but no intlammatory cell infiltrate or CMV inclusions. The parenchymal changes noted above were attributed to the sepsis and total parenteral nutririon. Pancreatic islets were Jetected in several portal triaus in tissue sections from the anterior inferior edge of the right lohe of the liver. The islets were contained within small venulcs in the interstitium of the portal tracts (Fig.  I A l. An immunohistochemical ~tain for insulin confirmed the presence of insulin-containing cells (Fig.  I B l. It is or note that the pauent never hecame insulin independent after islet allotransplantation. We attrlhuted the exogenous insulin requirement to the complicated postoperative course (sepsis' and the need for I.:ontlnuous total paren.teillnutntion. Nevcrtheless. signiticant plasma C-peptide levels (1-1) were ohserved during the postoperative course: 2.15 :' :: 1.27 [".\1. 1/ =~O. versus C-pepude plasma levels in normal controls of 2.1t) ::!: 1.22 p.\1. 1/ = 10.
DISCUSS(ON
rhe findings in this patient Indicated that human i"lets C;ln survIve in the liver of transplanted patlcnts. Jcsplte positive cross-match. no HLA anti-.'!en matl.:h. ,lnd immunosuppressive monotherapy \\ Ith low-dose FK-SOo. \\ hich was discontinued 12 davs hctore the pallen! Liied .. \1-.0. [he findings "ll~-gest that upper abdominal exenteration and liver transplantation may constitute a favorable environment for allogeneic human islets. providing additional evidence in support of previous experimental results on combined liver-islet transplantation (IO)' Since this patient. we have been able to document the presence of insulin-containing cells in both wedge and needle liver biopsies in patients who received either liver-islet or kidney-islet allografts ( 15).
